Metabolic	B:C3853758
signatures	I:C3853758
of	O
birthweight	O
in	O
18	O
288	O
adolescents	O
and	O
adults	O
.	O

Lower	B:C0024032
birthweight	I:C0024032
is	O
associated	O
with	O
increased	O
susceptibility	I:C0243095
to	O
cardiometabolic	O
diseases	I:C0025517
in	O
adulthood	O
,	O
but	O
the	O
underlying	O
molecular	O
pathways	I:C1704259
are	O
incompletely	O
understood	O
.	O

Lower	O
birthweight	I:C0024032
is	O
associated	O
with	O
increased	B:C0243095
susceptibility	I:C0243095
to	O
cardiometabolic	O
diseases	I:C0025517
in	O
adulthood	O
,	O
but	O
the	O
underlying	O
molecular	O
pathways	I:C1704259
are	O
incompletely	O
understood	O
.	O

Lower	O
birthweight	I:C0024032
is	O
associated	O
with	O
increased	O
susceptibility	I:C0243095
to	O
cardiometabolic	B:C0025517
diseases	I:C0025517
in	O
adulthood	O
,	O
but	O
the	O
underlying	O
molecular	O
pathways	I:C1704259
are	O
incompletely	O
understood	O
.	O

Lower	O
birthweight	I:C0024032
is	O
associated	O
with	O
increased	O
susceptibility	I:C0243095
to	O
cardiometabolic	O
diseases	I:C0025517
in	O
adulthood	O
,	O
but	O
the	O
underlying	O
molecular	B:C1704259
pathways	I:C1704259
are	O
incompletely	O
understood	O
.	O

We	O
examined	O
associations	O
of	O
birthweight	O
with	O
a	O
comprehensive	O
metabolic	B:C3853758
profile	I:C3853758
measured	O
in	O
adolescents	O
and	O
adults	O
.	O

High	O
-	O
throughput	O
nuclear	O
magnetic	O
resonance	O
metabolomics	B:C1328813
and	O
biochemical	O
assays	I:C0005507
were	O
used	O
to	O
quantify	O
87	O
circulating	O
metabolic	O
measures	O
in	O
seven	O
cohorts	O
from	O
Finland	O
and	O
the	O
UK	O
,	O
comprising	O
altogether	O
18	O
288	O
individuals	O
(	O
mean	O
age	O
26	O
years	O
,	O
range	O
15	O
-	O
75	O
)	O
.	O

High	O
-	O
throughput	O
nuclear	O
magnetic	O
resonance	O
metabolomics	O
and	O
biochemical	B:C0005507
assays	I:C0005507
were	O
used	O
to	O
quantify	O
87	O
circulating	O
metabolic	O
measures	O
in	O
seven	O
cohorts	O
from	O
Finland	O
and	O
the	O
UK	O
,	O
comprising	O
altogether	O
18	O
288	O
individuals	O
(	O
mean	O
age	O
26	O
years	O
,	O
range	O
15	O
-	O
75	O
)	O
.	O

High	O
-	O
throughput	O
nuclear	O
magnetic	O
resonance	O
metabolomics	O
and	O
biochemical	O
assays	I:C0005507
were	O
used	O
to	O
quantify	O
87	O
circulating	O
metabolic	O
measures	O
in	O
seven	O
cohorts	B:C0599755
from	O
Finland	O
and	O
the	O
UK	O
,	O
comprising	O
altogether	O
18	O
288	O
individuals	O
(	O
mean	O
age	O
26	O
years	O
,	O
range	O
15	O
-	O
75	O
)	O
.	O

High	O
-	O
throughput	O
nuclear	O
magnetic	O
resonance	O
metabolomics	O
and	O
biochemical	O
assays	I:C0005507
were	O
used	O
to	O
quantify	O
87	O
circulating	O
metabolic	O
measures	O
in	O
seven	O
cohorts	O
from	O
Finland	B:C0016132
and	O
the	O
UK	O
,	O
comprising	O
altogether	O
18	O
288	O
individuals	O
(	O
mean	O
age	O
26	O
years	O
,	O
range	O
15	O
-	O
75	O
)	O
.	O

High	O
-	O
throughput	O
nuclear	O
magnetic	O
resonance	O
metabolomics	O
and	O
biochemical	O
assays	I:C0005507
were	O
used	O
to	O
quantify	O
87	O
circulating	O
metabolic	O
measures	O
in	O
seven	O
cohorts	O
from	O
Finland	O
and	O
the	O
UK	B:C0041700
,	O
comprising	O
altogether	O
18	O
288	O
individuals	O
(	O
mean	O
age	O
26	O
years	O
,	O
range	O
15	O
-	O
75	O
)	O
.	O

High	O
-	O
throughput	O
nuclear	O
magnetic	O
resonance	O
metabolomics	O
and	O
biochemical	O
assays	I:C0005507
were	O
used	O
to	O
quantify	O
87	O
circulating	O
metabolic	O
measures	O
in	O
seven	O
cohorts	O
from	O
Finland	O
and	O
the	O
UK	O
,	O
comprising	O
altogether	O
18	O
288	O
individuals	B:C0237401
(	O
mean	O
age	O
26	O
years	O
,	O
range	O
15	O
-	O
75	O
)	O
.	O

Metabolic	O
associations	O
with	O
birthweight	O
were	O
assessed	O
by	O
linear	O
regression	O
models	O
adjusted	O
for	O
sex	O
,	O
gestational	O
age	O
and	O
age	O
at	O
blood	B:C0190979
sampling	I:C0190979
.	O

The	O
metabolic	O
associations	O
with	O
birthweight	O
were	O
compared	O
with	O
the	O
corresponding	O
associations	O
with	O
adult	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
.	O

The	O
metabolic	O
associations	O
with	O
birthweight	O
were	O
compared	O
with	O
the	O
corresponding	O
associations	O
with	O
adult	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
)	O
.	O

Lower	B:C0024032
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
was	O
adversely	O
associated	O
with	O
cardiometabolic	O
biomarkers	O
,	O
including	O
lipoprotein	O
subclasses	O
,	O
fatty	O
acids	I:C0015684
,	O
amino	O
acids	I:C0002520
and	O
markers	O
of	O
inflammation	O
and	O
impaired	O
liver	I:C0086565
function	I:C0086565
(	O
P	O
<	O
0.0015	O
for	O
46	O
measures	O
)	O
.	O

Lower	O
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
was	O
adversely	O
associated	O
with	O
cardiometabolic	O
biomarkers	B:C0005516
,	O
including	O
lipoprotein	O
subclasses	O
,	O
fatty	O
acids	I:C0015684
,	O
amino	O
acids	I:C0002520
and	O
markers	O
of	O
inflammation	O
and	O
impaired	O
liver	I:C0086565
function	I:C0086565
(	O
P	O
<	O
0.0015	O
for	O
46	O
measures	O
)	O
.	O

Lower	O
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
was	O
adversely	O
associated	O
with	O
cardiometabolic	O
biomarkers	O
,	O
including	O
lipoprotein	B:C0023820
subclasses	O
,	O
fatty	O
acids	I:C0015684
,	O
amino	O
acids	I:C0002520
and	O
markers	O
of	O
inflammation	O
and	O
impaired	O
liver	I:C0086565
function	I:C0086565
(	O
P	O
<	O
0.0015	O
for	O
46	O
measures	O
)	O
.	O

Lower	O
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
was	O
adversely	O
associated	O
with	O
cardiometabolic	O
biomarkers	O
,	O
including	O
lipoprotein	O
subclasses	B:C0445604
,	O
fatty	O
acids	I:C0015684
,	O
amino	O
acids	I:C0002520
and	O
markers	O
of	O
inflammation	O
and	O
impaired	O
liver	I:C0086565
function	I:C0086565
(	O
P	O
<	O
0.0015	O
for	O
46	O
measures	O
)	O
.	O

Lower	O
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
was	O
adversely	O
associated	O
with	O
cardiometabolic	O
biomarkers	O
,	O
including	O
lipoprotein	O
subclasses	O
,	O
fatty	B:C0015684
acids	I:C0015684
,	O
amino	O
acids	I:C0002520
and	O
markers	O
of	O
inflammation	O
and	O
impaired	O
liver	I:C0086565
function	I:C0086565
(	O
P	O
<	O
0.0015	O
for	O
46	O
measures	O
)	O
.	O

Lower	O
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
was	O
adversely	O
associated	O
with	O
cardiometabolic	O
biomarkers	O
,	O
including	O
lipoprotein	O
subclasses	O
,	O
fatty	O
acids	I:C0015684
,	O
amino	B:C0002520
acids	I:C0002520
and	O
markers	O
of	O
inflammation	O
and	O
impaired	O
liver	I:C0086565
function	I:C0086565
(	O
P	O
<	O
0.0015	O
for	O
46	O
measures	O
)	O
.	O

Lower	O
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
was	O
adversely	O
associated	O
with	O
cardiometabolic	O
biomarkers	O
,	O
including	O
lipoprotein	O
subclasses	O
,	O
fatty	O
acids	I:C0015684
,	O
amino	O
acids	I:C0002520
and	O
markers	B:C0005516
of	O
inflammation	O
and	O
impaired	O
liver	I:C0086565
function	I:C0086565
(	O
P	O
<	O
0.0015	O
for	O
46	O
measures	O
)	O
.	O

Lower	O
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
was	O
adversely	O
associated	O
with	O
cardiometabolic	O
biomarkers	O
,	O
including	O
lipoprotein	O
subclasses	O
,	O
fatty	O
acids	I:C0015684
,	O
amino	O
acids	I:C0002520
and	O
markers	O
of	O
inflammation	B:C0021368
and	O
impaired	O
liver	I:C0086565
function	I:C0086565
(	O
P	O
<	O
0.0015	O
for	O
46	O
measures	O
)	O
.	O

Lower	O
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
was	O
adversely	O
associated	O
with	O
cardiometabolic	O
biomarkers	O
,	O
including	O
lipoprotein	O
subclasses	O
,	O
fatty	O
acids	I:C0015684
,	O
amino	O
acids	I:C0002520
and	O
markers	O
of	O
inflammation	O
and	O
impaired	B:C0086565
liver	I:C0086565
function	I:C0086565
(	O
P	O
<	O
0.0015	O
for	O
46	O
measures	O
)	O
.	O

Associations	O
were	O
consistent	O
across	O
cohorts	B:C0599755
with	O
different	O
ages	O
at	O
metabolic	O
profiling	I:C3853758
,	O
but	O
the	O
magnitudes	O
were	O
weak	O
.	O

Associations	O
were	O
consistent	O
across	O
cohorts	O
with	O
different	O
ages	O
at	O
metabolic	B:C3853758
profiling	I:C3853758
,	O
but	O
the	O
magnitudes	O
were	O
weak	O
.	O

The	O
pattern	O
of	O
metabolic	O
deviations	B:C0012727
associated	O
with	O
lower	O
birthweight	I:C0024032
resembled	O
the	O
metabolic	O
signature	I:C3853758
of	O
higher	O
adult	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
R(	O
2	O
)	O
=	O
0.77	O
)	O
assessed	O
at	O
the	O
same	O
time	O
as	O
the	O
metabolic	O
profiling	I:C3853758
.	O

The	O
pattern	O
of	O
metabolic	O
deviations	O
associated	O
with	O
lower	B:C0024032
birthweight	I:C0024032
resembled	O
the	O
metabolic	O
signature	I:C3853758
of	O
higher	O
adult	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
R(	O
2	O
)	O
=	O
0.77	O
)	O
assessed	O
at	O
the	O
same	O
time	O
as	O
the	O
metabolic	O
profiling	I:C3853758
.	O

The	O
pattern	O
of	O
metabolic	O
deviations	O
associated	O
with	O
lower	O
birthweight	I:C0024032
resembled	O
the	O
metabolic	B:C3853758
signature	I:C3853758
of	O
higher	O
adult	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
R(	O
2	O
)	O
=	O
0.77	O
)	O
assessed	O
at	O
the	O
same	O
time	O
as	O
the	O
metabolic	O
profiling	I:C3853758
.	O

The	O
pattern	O
of	O
metabolic	O
deviations	O
associated	O
with	O
lower	O
birthweight	I:C0024032
resembled	O
the	O
metabolic	O
signature	I:C3853758
of	O
higher	O
adult	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
(	O
R(	O
2	O
)	O
=	O
0.77	O
)	O
assessed	O
at	O
the	O
same	O
time	O
as	O
the	O
metabolic	O
profiling	I:C3853758
.	O

The	O
pattern	O
of	O
metabolic	O
deviations	O
associated	O
with	O
lower	O
birthweight	I:C0024032
resembled	O
the	O
metabolic	O
signature	I:C3853758
of	O
higher	O
adult	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
R(	O
2	O
)	O
=	O
0.77	O
)	O
assessed	O
at	O
the	O
same	O
time	O
as	O
the	O
metabolic	B:C3853758
profiling	I:C3853758
.	O

The	O
resemblance	O
indicated	O
that	O
1	O
kg	O
lower	B:C0024032
birthweight	I:C0024032
is	O
associated	O
with	O
similar	O
metabolic	O
aberrations	O
as	O
caused	O
by	O
0.92	O
units	O
higher	O
body	O
mass	I:C1305855
index	I:C1305855
in	O
adulthood	O
.	O

The	O
resemblance	O
indicated	O
that	O
1	O
kg	O
lower	O
birthweight	I:C0024032
is	O
associated	O
with	O
similar	O
metabolic	O
aberrations	O
as	O
caused	O
by	O
0.92	O
units	O
higher	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
in	O
adulthood	O
.	O

Lower	B:C0024032
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
is	O
associated	O
with	O
adverse	O
biomarker	O
aberrations	O
across	O
multiple	O
metabolic	O
pathways	O
.	O

Lower	O
birthweight	I:C0024032
adjusted	O
for	O
gestational	O
age	O
is	O
associated	O
with	O
adverse	O
biomarker	B:C0005516
aberrations	O
across	O
multiple	O
metabolic	O
pathways	O
.	O

Coherent	O
metabolic	B:C3853758
signatures	I:C3853758
between	O
lower	O
birthweight	I:C0024032
and	O
higher	O
adult	O
adiposity	O
suggest	O
that	O
shared	O
molecular	O
pathways	I:C1704259
may	O
potentially	O
underpin	O
the	O
metabolic	O
deviations	O
.	O

Coherent	O
metabolic	O
signatures	I:C3853758
between	O
lower	B:C0024032
birthweight	I:C0024032
and	O
higher	O
adult	O
adiposity	O
suggest	O
that	O
shared	O
molecular	O
pathways	I:C1704259
may	O
potentially	O
underpin	O
the	O
metabolic	O
deviations	O
.	O

Coherent	O
metabolic	O
signatures	I:C3853758
between	O
lower	O
birthweight	I:C0024032
and	O
higher	O
adult	O
adiposity	O
suggest	O
that	O
shared	O
molecular	B:C1704259
pathways	I:C1704259
may	O
potentially	O
underpin	O
the	O
metabolic	O
deviations	O
.	O

Coherent	O
metabolic	O
signatures	I:C3853758
between	O
lower	O
birthweight	I:C0024032
and	O
higher	O
adult	O
adiposity	O
suggest	O
that	O
shared	O
molecular	O
pathways	I:C1704259
may	O
potentially	O
underpin	O
the	O
metabolic	O
deviations	B:C0012727
.	O

However	O
,	O
the	O
magnitudes	O
of	O
metabolic	O
associations	O
with	O
birthweight	O
are	O
modest	O
in	O
comparison	O
to	O
the	O
effects	O
of	O
adiposity	O
,	O
implying	O
that	O
birthweight	O
is	O
only	O
a	O
weak	O
indicator	O
of	O
the	O
metabolic	B:C3853758
risk	I:C3853758
profile	I:C3853758
in	O
adulthood	O
.	O

